- Pharm.D., University of California at San Francisco, School of Pharmacy
- M.S. in Medical Sciences, emphasis in Clinical Investigation, University of Florida
Dr. Cooper-DeHoff is a Associate Professor in the Department of Pharmacotherapy and Translational Research, and the Department of Pharmaceutics in the College of Pharmacy, and in the Division of Cardiovascular Medicine, College of Medicine at the University of Florida.
- 2014 – Fellow of the American College of Clinical Pharmacy
- 2009 – Research featured by the American Society of Hypertension
- 2008 – Received the Clinical Science Award from the Consortium for Southeastern Hypertension Control
- 2007 – Named Fellow of the American Heart Association
- American Society of Hypertension
- American Heart Association
- American College of Cardiology
- Florida Society of Hospital Pharmacists
- North Central Florida Society of Hospital Pharmacists
Dr. Cooper-DeHoff’s research interest include hypertension, metabolic syndrome and diabetes, and she is the principal investigator for the NIH-funded Career Development Award (K23) entitled “Metabolic Effects of Antihypertensive Drugs.” She was also an investigator of the International Verapamil Trandolapril Study (INVEST) which evaluated hypertension treatments in elderly coronary artery disease patients, and is a co-investigator on two NIH grants evaluating pharmacogenetic associations in hypertension. She is a member of the American Heart Association, American Society of Hypertension, American College of Cardiology and Florida Society of Hospital Pharmacists. Dr. Cooper-DeHoff serves as a scientific reviewer for several Journals, including Circulation, Annals of Pharmacotherapy, Lancet and many others.
Full Publication List via PubMed